DEXCOM INC (DXCM) has 17 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 11 sales totalling $8.4M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 14, 2026 | AUGUSTINOS NICHOLAS Director | −$679,769 | 8,089 | −22% | Yes | |
|
|
||||||
| Sept. 16, 2026 filed Sept. 15, 2026 | Brown Michael Jon EVP Chief Legal Compliance Off | −$142,868 | 1,700 | −2% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | Sylvain Jereme M EVP, Chief Financal Officer | −$302,936 | 3,638 | −2% | Yes | |
|
|
||||||
| Sept. 10, 2026 | Boehnlein Glenn S Director | $0 | 5,841 | New | No | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 27, 2026 | Stern Sadie EVP Chief People & Culture Off | −$226,669 | 2,565 | −2% | Yes | |
|
|
||||||
Showing the 5 most recent of 17 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free